» Authors » Elsa M Valdizan

Elsa M Valdizan

Explore the profile of Elsa M Valdizan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 583
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mato S, Pilar-Cuellar F, Valdizan E, Gonzalez-Maeso J, Rodriguez-Puertas R, Meana J, et al.
Biochem Pharmacol . 2018 Aug; 157:258-265. PMID: 30099006
Brain endocannabinoid system is proposed to play a role in the pathogenesis of affective disorders. In the present study, we analyzed the functionality of the cannabinoid receptor type 1 (CB...
2.
Crespo-Facorro B, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, Valdizan E, Perez-Iglesias R, Amado-Senaris J, et al.
Schizophr Res . 2017 Feb; 189:134-141. PMID: 28223031
Rationale: Hyperprolactinemia is considered a troubling adverse effect of antipsychotics. Direct comparisons among second generation antipsychotics are scant in clinical practice. We hypothesize prolactin-sparing second-generation antipsychotics may have differential effects...
3.
Jimenez-Sanchez L, Linge R, Campa L, Valdizan E, Pazos A, Diaz A, et al.
Neuropharmacology . 2016 Apr; 108:91-102. PMID: 27108934
Deep brain stimulation (DBS) is a treatment that has shown some efficacy in treatment-resistant depression. In particular, DBS of the subcallosal cingulate gyrus (Brodmann's area 25, Cg25) has been successfully...
4.
Son J, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Moreno T, Parrilla-Escobar M, Valdizan E, et al.
J Clin Psychiatry . 2016 Jan; 77(4):492-500. PMID: 26759992
Objective: The timing of antipsychotic discontinuation in patients who have fully recovered from their initial episode of psychosis is still open to discussion. We aimed to evaluate the risk of...
5.
Herrero A, Pinto A, Colon-Bolea P, Casar B, Jones M, Agudo-Ibanez L, et al.
Cancer Cell . 2015 Aug; 28(2):170-82. PMID: 26267534
Nearly 50% of human malignancies exhibit unregulated RAS-ERK signaling; inhibiting it is a valid strategy for antineoplastic intervention. Upon activation, ERK dimerize, which is essential for ERK extranuclear, but not...
6.
Rapado-Castro M, Pazos A, Fananas L, Bernardo M, Ayuso-Mateos J, Leza J, et al.
Rev Psiquiatr Salud Ment . 2015 Feb; 8(2):65-74. PMID: 25682021
The number of large collaborative research networks in mental health is increasing. Training programs are an essential part of them. We critically review the specific implementation of a research training...
7.
Pinacho R, Valdizan E, Pilar-Cuellar F, Prades R, Tarrago T, Haro J, et al.
J Psychiatr Res . 2014 Sep; 58:189-96. PMID: 25175639
Altered levels of transcription factor specificity protein 4 (SP4) and 1 (SP1) in the cerebellum, prefrontal cortex and/or lymphocytes have been reported in severe psychiatric disorders, including early psychosis, bipolar...
8.
Erdozain A, Rubio M, Valdizan E, Pazos A, Meana J, Fernandez-Ruiz J, et al.
Addict Biol . 2014 Jul; 20(4):773-83. PMID: 25041461
There is strong biochemical, pharmacological and genetic evidence for the involvement of the endocannabinoid system (ECS) in alcohol dependence. However, the majority of studies have been performed in animal models....
9.
Vidal R, Castro E, Pilar-Cuellar F, Pascual-Brazo J, Diaz A, Rojo M, et al.
Curr Pharm Des . 2013 Nov; 20(23):3751-62. PMID: 24180399
The regulation of the activity of brain monoaminergic systems has been the focus of attention of many studies since the first antidepressant drug emerged 50 years ago. The search for...
10.
Pilar-Cuellar F, Vidal R, Diaz A, Castro E, Dos Anjos S, Vargas V, et al.
Curr Pharm Des . 2013 Nov; 20(23):3776-94. PMID: 24180397
In the last years it has been proposed that the antidepressant action is mediated not only by changes in monoamine levels but also in association with modifications involving cell proliferation...